Comparative treatment costs of risk‐stratified therapy for childhood acute lymphoblastic leukemia in India

por Mungle, Tushar, Das, Nandana, Pal, Saikat, Gogoi, Manash Pratim, Das, Parag, Ghara, Niharendu, Ghosh, Debjani, Arora, Ramandeep Singh, Bhakta, Nickhill, Saha, Vaskar, Krishnan, Shekhar
Publicado 2022

Unsatisfactory quality of E. coli asparaginase biogenerics in India: Implications for clinical outcomes in acute lymphoblastic leukaemia

por Sidhu, Jasmeet, Gogoi, Manash Pratim, Agarwal, Praveen, Mukherjee, Tathagata, Saha, Debparna, Bose, Priyanka, Roy, Prakriti, Phadke, Yogesh, Sonawane, Bhatu, Paul, Pritha, Saha, Vaskar, Krishnan, Shekhar
Publicado 2021

Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute...

por Das, Nandana, Banavali, Shripad, Bakhshi, Sameer, Trehan, Amita, Radhakrishnan, Venkatraman, Seth, Rachna, Arora, Brijesh, Narula, Gaurav, Sinha, Subir, Roy, Prakriti, Gogoi, Manash Pratim, Chatterjee, Sayan, Abraham, Bindhu, Das, Parag, Saha, Vaskar, Krishnan, Shekhar
Publicado 2022

Activity and toxicity of intramuscular 1000 iu/m(2) polyethylene glycol‐E. coli L‐asparaginase in the UKALL 2003 and UKALL 2011 clinical trials

por Sidhu, Jasmeet, Masurekar, Ashish Narayan, Gogoi, Manash Pratim, Fong, Caroline, Ioannou, Tasos, Lodhi, Taha, Parker, Catriona, Liu, Jizhong, Kirkwood, Amy A., Moorman, Anthony V., Das, Kiranmoy, Goulden, Nicholas J., Vora, Ajay, Saha, Vaskar, Krishnan, Shekhar
Publicado 2022